A.F.P. Planvital S.A. (PLANVITAL) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of A.F.P. Planvital S.A. stock CLP 504, price CLP 252, upside +100.0%, quality 74 out of 100. Rating: strongly undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 1.64 CLP – 302.41 CLP · fair‑value band 300.01 CLP – 821.10 CLP · the 251.90 CLP price screens below the 503.80 CLP fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow A.F.P. Planvital in your weekly email
Every Wednesday you see whether A.F.P. Planvital is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Administradora de Fondos de Pensiones PlanVital S.A. is a privately owned investment manager. The firm manages pension funds and individual retirement accounts. It makes its investments in the public equity markets of Chile.
Show moreShow less
Administradora de Fondos de Pensiones PlanVital S.A was founded in 1981 and is based in Santiago, Chile.
Stock analysis
A.F.P. Planvital S.A. (PLANVITAL) currently trades at 251.90 CLP, while our model-based Fair Value estimate is 503.80 CLP, implying the stock looks roughly 50% undervalued today.
Show more
Valuation
Bull case: the Earnings-Based group reads highest at a median of 879.19 CLP per share, and 9 of the 13 models we run sit above the 251.90 CLP price.
Bear case: the Dividend Discount group reads lowest at 190.31 CLP, and 4 of the 13 models stay below the price. Data coverage for this calculation is low.
Scenario range: 300.01 CLP (bear) to 821.10 CLP (bull), the price of 251.90 CLP sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 74/100 (solid quality), in the Financial Services sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
A.F.P. Planvital S.A. reported revenue of 132B CLP in FY2025 versus 79.2B CLP in FY2021, a compound +13.6%/yr. Reported net income was 68.2B CLP in FY2025, compounding +27.7%/yr from FY2021.
Key figures
Market cap 513B CLP (≈ $526M) Small · P/S ratio 3.29 · EPS (TTM) 0.0300 CLP · Dividend yield 4.4% · Net margin 51.8% · Return on equity 43.3% · Return on assets (EBIT) 36.0% (5-year average) · Operating margin 61.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 92 out of 100 (low confidence).
What moves the price
The share trades about 17% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −16% fair-value upside, at 100%, PLANVITAL screens cheaper than that median.
Fair Value models
Bear300.01 CLPFair Value 503.80 CLPBull821.10 CLP
Price 251.90 CLP · Upside +100.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+10.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.0%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in CLP ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in CLP: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+26.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+21.6%
Dividend (yield on the price)4.4%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.44% → 54%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−3.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Chile: IMF forecast 3.0% a year to 2030, 4.5% from 2016 to 2025) that is about −6.6% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 587 stocks
Beats the industry median on 11/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score74 · Top 25%
Fair Value upside+100.0% · Top 25%
Profitability
Return on equity (12 months)43.3% · Top 25%
Return on assets29.6% · Top 25%
Net margin (12 months)44.5% · Above median
Operating margin (12 months)61.6% · Above median
Growth and dividend
Revenue growth (quarter YoY)15.5% · Above median
Dividend yield (12 months)4.4% · Above median
Valuation Multiplesvs Asset Management median · lower = cheaper
P/B3.23× · Priciest 25%
P/S (12 months)3.27× · Cheaper than median
Price / free cash flow (fiscal year)9.5× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is A.F.P. Planvital S.A. (PLANVITAL) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 503.80 CLP versus a price of 251.90 CLP, about +100% upside (undervalued).
What is the fair value of PLANVITAL?
Our model-based fair value for A.F.P. Planvital S.A. is 503.80 CLP (as of Nov 7, 2026), built from audited fundamentals. The current price: 251.90 CLP.
What is the quality score of PLANVITAL?
A.F.P. Planvital S.A. has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for A.F.P. Planvital S.A. (PLANVITAL)?
Our model-based price target is the fair value of 503.80 CLP (as of Nov 7, 2026) from 13 valuation models. Cautious scenario 300.01 CLP, optimistic scenario 821.10 CLP. It is a calculation from audited fundamentals, not an analyst target.
What is the A.F.P. Planvital S.A. stock forecast for 2026?
Our models put fair value at 503.80 CLP, about +100% upside versus a price of 251.90 CLP (undervalued). Cautious scenario 300.01 CLP, optimistic scenario 821.10 CLP. The calculation is refreshed regularly with new filings.
What is the revenue of A.F.P. Planvital S.A. (PLANVITAL)?
A.F.P. Planvital S.A. reported trailing-twelve-month revenue of about 157B CLP (latest available figure, as of Nov 7, 2026).
Does A.F.P. Planvital S.A. pay a dividend?
A.F.P. Planvital S.A. currently shows a dividend yield of 4.42% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of A.F.P. Planvital S.A. (PLANVITAL) and when is the ex-dividend date?
A.F.P. Planvital S.A. pays a dividend of 11.13 CLP per share a year, a dividend yield of 4.4%. The last ex-dividend date was May 8, 2026. A dividend has been paid every year since at least 2018. Free cash flow covers the dividend 2.38 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into A.F.P. Planvital S.A. (PLANVITAL)?
For today's price to be fair in a discounted-cash-flow model, A.F.P. Planvital S.A. would have to grow free cash flow by -3.8 % per year for five years (discount rate 10.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.8 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of PLANVITAL use?
Our models discount A.F.P. Planvital S.A. at 10.6 %: a base by market capitalisation (small), damped by beta 0.05, country premium for Chile. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For A.F.P. Planvital S.A. that is -3.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.6 %) and the same formula as our fair value.
How much growth has A.F.P. Planvital S.A. (PLANVITAL) delivered so far?
Over the past 5 years revenue at A.F.P. Planvital S.A. grew +13.8 % a year. The price currently implies free-cash-flow growth of -3.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of A.F.P. Planvital S.A. (PLANVITAL) growing?
The median revenue growth in the sector is +9.2 % a year. That is the yardstick for the growth priced into A.F.P. Planvital S.A. (-3.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of A.F.P. Planvital S.A. (PLANVITAL)?
The free-cash-flow yield on the price is 10.54 %: that much free cash flow A.F.P. Planvital S.A. produces per unit of market value. When it exceeds the discount rate of our models (10.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of A.F.P. Planvital S.A. (PLANVITAL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For A.F.P. Planvital S.A. it is 503.80 CLP per share (as of Nov 7, 2026), against a price of 251.90 CLP. It is the blended result of 13 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is A.F.P. Planvital S.A. stock overvalued or undervalued in 2026?
As of Nov 7, 2026, PLANVITAL trades below its calculated fair value: price 251.90 CLP, fair value 503.80 CLP, a gap of about +100% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PLANVITAL?
No. The price is what the market pays today (251.90 CLP); the fair value is what the company's own numbers justify (503.80 CLP). For A.F.P. Planvital S.A. the two are 251.90 CLP per share apart. That gap is exactly why we show both numbers side by side.
How much is A.F.P. Planvital S.A. worth?
The market values A.F.P. Planvital S.A. at about 513B CLP (market capitalisation, as of Nov 7, 2026). Per share that is 251.90 CLP; our models calculate a fair value of 503.80 CLP per share.
What do the bullish and bearish scenarios say about PLANVITAL?
Our models span a range for A.F.P. Planvital S.A.: cautious scenario 300.01 CLP, base 503.80 CLP, optimistic 821.10 CLP per share (as of Nov 7, 2026, price 251.90 CLP). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of A.F.P. Planvital S.A. (PLANVITAL)?
Balance-sheet figures for A.F.P. Planvital S.A. (as of Nov 7, 2026): return on equity 43.3%. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is PLANVITAL from its 52-week high?
A.F.P. Planvital S.A. trades at 251.90 CLP, about 17% below its 52-week high of 302.41 CLP and 1% above the low of 248.75 CLP (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 503.80 CLP is for.
Which stocks are comparable to A.F.P. Planvital S.A.?
From the same area (Financial Services) we also value Blackstone Inc, Brookfield Asset Management Ltd, KKR & Co, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is A.F.P. Planvital S.A. stock attractive at the current price?
The data as of Nov 7, 2026: price 251.90 CLP, calculated fair value 503.80 CLP (+100%), Quality Score 74/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PLANVITAL calculated?
We run A.F.P. Planvital S.A. through 13 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 503.80 CLP builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. A.F.P. Planvital S.A. currently trades 50% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of A.F.P. Planvital S.A. (PLANVITAL)?
The closing price on Nov 6, 2026 was 251.90 CLP. Our model-based fair value is 503.80 CLP, about +100% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with A.F.P. Planvital S.A. right now?
The price is below even our cautious bear case (300.01 CLP). The market is more pessimistic than our downside scenario. The model range is unusually wide (300.01 CLP to 821.10 CLP). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (74/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of A.F.P. Planvital S.A.
How large is the market capitalisation of A.F.P. Planvital S.A. (PLANVITAL)?
The market capitalisation of A.F.P. Planvital S.A. is 513B CLP (≈ $526M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of A.F.P. Planvital S.A. (PLANVITAL)?
The price-to-sales ratio of A.F.P. Planvital S.A. is 3.29 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of A.F.P. Planvital S.A. (PLANVITAL)?
Earnings per share at A.F.P. Planvital S.A. are 0.0300 CLP. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of A.F.P. Planvital S.A. (PLANVITAL)?
The dividend yield of A.F.P. Planvital S.A. is 4.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of A.F.P. Planvital S.A. (PLANVITAL)?
The net margin of A.F.P. Planvital S.A. is 51.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of A.F.P. Planvital S.A. (PLANVITAL)?
The return on equity (ROE) of A.F.P. Planvital S.A. is 43.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of A.F.P. Planvital S.A. (PLANVITAL)?
On an EBIT basis the return on assets of A.F.P. Planvital S.A. is 36.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of A.F.P. Planvital S.A. (PLANVITAL)?
The operating margin of A.F.P. Planvital S.A. is 61.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at A.F.P. Planvital S.A. (PLANVITAL)?
Revenue at A.F.P. Planvital S.A. is growing +15.5% versus a year earlier (3y avg +11.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at A.F.P. Planvital S.A. (PLANVITAL)?
Earnings per share at A.F.P. Planvital S.A. are growing +15.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does A.F.P. Planvital S.A. (PLANVITAL) carry?
The net debt of A.F.P. Planvital S.A. is 4.4B CLP (fiscal year 2017, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch A.F.P. Planvital S.A. in the live analysis
One click puts A.F.P. Planvital S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026